As Korea Pharmas Look To U.S., U.S. VC Looks To Korea

NEW YORK - Oxford Bioscience Partners has chosen Korea as its first Asian country to invest in via a partnership with Hanwha Venture Capital in Seoul

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Scrip